Chinese scientists have revealed a hidden metabolic partnership between breast cancer cells and immune cells that drives ...
2h
News-Medical.Net on MSNBlocking an enzyme to overcome immunotherapy resistance in melanoma patientsAbout 65% of melanoma patients do not respond to immunotherapy. New work by the team of Prof. Max Mazzone (VIB-KU Leuven ...
Cardiac macrophages in newborn mice promoted heart cell proliferation after injury, offering a potential approach to ...
About 65% of melanoma patients do not respond to immunotherapy. New work by the team of Prof. Max Mazzone (VIB-KU Leuven Center for Cancer Biology) discovered that an enzyme called HPGDS (expressed in ...
New methods for deriving macrophages from induced pluripotent stem cells are easier to scale and provide more clinically ...
About 65% of melanoma patients do not respond to immunotherapy. New work by the team of Prof. Max Mazzone (VIB-KU Leuven ...
This short-term memory changes how macrophages respond to subsequent infections and immune signals—sometimes giving the cells a type of tolerance that makes them less responsive, sometimes ...
Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against potential ...
Chinese scientists have revealed a hidden metabolic partnership between breast cancer cells and immune cells that drives aggressive tumor behavior and resistance to immunotherapies. The study sheds ...
This study provides proof-of-principle data for the use of trained immunity to modulate macrophage interactions with tumours. The study makes a valuable contribution to the field of trained immunity.
About 65% of melanoma patients do not respond to immunotherapy. New work by the team of Prof. Max Mazzone (VIB-KU Leuven Center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results